{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:02:01Z","timestamp":1793721721080,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006662","name":"Ardabil University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006662","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00408-020-00348-z","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T08:02:29Z","timestamp":1585036949000},"page":"515-523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Correlations Between Serum Decoy Receptor 3 and Airflow Limitation and Quality of Life in Male Patients with Stable Stage and Acute Exacerbation of COPD"],"prefix":"10.1007","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7480-5651","authenticated-orcid":false,"given":"Hassan","family":"Ghobadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1519-7611","authenticated-orcid":false,"given":"Mohammad Reza","family":"Aslani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"348_CR1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00164-2019","author":"D Singh","year":"2019","unstructured":"Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin DM, Han M (2019) Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.00164-2019","journal-title":"Eur Respir J"},{"issue":"6","key":"348_CR2","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1183\/09031936.00109906","volume":"29","author":"BR Celli","year":"2007","unstructured":"Celli BR, Barnes PJ (2007) Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 29(6):1224\u20131238. https:\/\/doi.org\/10.1183\/09031936.00109906","journal-title":"Eur Respir J"},{"issue":"8","key":"348_CR3","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1513\/pats.200706-071TH","volume":"4","author":"EF Wouters","year":"2007","unstructured":"Wouters EF, Groenewegen KH, Dentener MA, Vernooy JH (2007) Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc Am Thorac Soc 4(8):626\u2013634. https:\/\/doi.org\/10.1513\/pats.200706-071TH","journal-title":"Proc Am Thorac Soc"},{"issue":"1","key":"348_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1164\/rccm.200505-704OC","volume":"173","author":"JR Hurst","year":"2006","unstructured":"Hurst JR, Perera WR, Wilkinson TM, Donaldson GC, Wedzicha JA (2006) Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173(1):71\u201378. https:\/\/doi.org\/10.1164\/rccm.200505-704OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"348_CR5","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bcp.2011.01.011","volume":"81","author":"W-W Lin","year":"2011","unstructured":"Lin W-W, Hsieh S-L (2011) Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer. Biochem Pharmacol 81(7):838\u2013847. https:\/\/doi.org\/10.1016\/j.bcp.2011.01.011","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"348_CR6","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.3899\/jrheum.110245","volume":"38","author":"C-P Cheng","year":"2011","unstructured":"Cheng C-P, Sytwu H-K, Chang D-M (2011) Decoy receptor 3 attenuates collagen-induced arthritis by modulating T cell activation and B cell expansion. J Rheumatol 38(12):2522\u20132535. https:\/\/doi.org\/10.3899\/jrheum.110245","journal-title":"J Rheumatol"},{"issue":"3","key":"348_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1189\/jlb.0903448","volume":"75","author":"Y-C Chang","year":"2004","unstructured":"Chang Y-C, Hsu T-L, Lin H-H, Chio C-C, Chiu AW, Chen N-J, Lin C-H, Hsieh S-L (2004) Modulation of macrophage differentiation and activation by decoy receptor 3. J Leukoc Biol 75(3):486\u2013494. https:\/\/doi.org\/10.1189\/jlb.0903448","journal-title":"J Leukoc Biol"},{"issue":"1","key":"348_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jneuroim.2009.01.024","volume":"209","author":"AM Mueller","year":"2009","unstructured":"Mueller AM, Pedr\u00e9 X, Killian S, David M, Steinbrecher A (2009) The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid. J Neuroimmunol 209(1):57\u201364. https:\/\/doi.org\/10.1016\/j.jneuroim.2009.01.024","journal-title":"J Neuroimmunol"},{"issue":"8","key":"348_CR9","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2215\/cjn.08410811","volume":"7","author":"SC Hung","year":"2012","unstructured":"Hung SC, Hsu TW, Lin YP, Tarng DC (2012) Decoy receptor 3, a novel inflammatory marker, and mortality in hemodialysis patients. Clin J Am Soc Nephrol 7(8):1257\u20131265. https:\/\/doi.org\/10.2215\/cjn.08410811","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"348_CR10","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.4049\/jimmunol.174.3.1647","volume":"174","author":"C-R Yang","year":"2005","unstructured":"Yang C-R, Hsieh S-L, Ho F-M, Lin W-W (2005) Decoy receptor 3 increases monocyte adhesion to endothelial cells via NF-\u03baB-dependent up-regulation of intercellular adhesion molecule-1, VCAM-1, and IL-8 expression. J Immunol 174(3):1647\u20131656. https:\/\/doi.org\/10.4049\/jimmunol.174.3.1647","journal-title":"J Immunol"},{"issue":"6","key":"348_CR11","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1161\/01.ATV.0000166517.18801.a7","volume":"25","author":"DM Schrijvers","year":"2005","unstructured":"Schrijvers DM, De Meyer GR, Kockx MM, Herman AG, Martinet W (2005) Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler Thromb Vasc Biol 25(6):1256\u20131261. https:\/\/doi.org\/10.1161\/01.ATV.0000166517.18801.a7","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"348_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jfma.2016.01.007","volume":"116","author":"M-H Chen","year":"2017","unstructured":"Chen M-H, Kan H-T, Liu C-Y, Yu W-K, Lee S-S, Wang J-H, Hsieh S-L (2017) Serum decoy receptor 3 is a biomarker for disease severity in nonatopic asthma patients. J Formos Med Assoc 116(1):49\u201356. https:\/\/doi.org\/10.1016\/j.jfma.2016.01.007","journal-title":"J Formos Med Assoc"},{"issue":"13","key":"348_CR13","doi-asserted-by":"publisher","first-page":"10934","DOI":"10.18632\/oncotarget.23736","volume":"9","author":"L Gao","year":"2018","unstructured":"Gao L, Yang B, Zhang H, Ou Q, Lin Y, Zhang M, Zhang Z, Kim S, Wu B, Wang Z, Fu L, Lin J, Chen R, Lan R, Chen J, Chen W, Chen L, Zhang H, Han D, Chen J, Okunieff P, Lin J, Zhang L (2018) DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin. Oncotarget 9(13):10934\u201310944. https:\/\/doi.org\/10.18632\/oncotarget.23736","journal-title":"Oncotarget"},{"issue":"8","key":"348_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1164\/rccm.200902-0222OC","volume":"180","author":"C-Y Chen","year":"2009","unstructured":"Chen C-Y, Yang K-Y, Chen M-Y, Chen H-Y, Lin M-T, Lee Y-C, Perng R-P, Hsieh S-L, Yang P-C, Chou T-Y (2009) Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndrome. Am J Respir Crit 180(8):751\u2013760. https:\/\/doi.org\/10.1164\/rccm.200902-0222OC","journal-title":"Am J Respir Crit"},{"issue":"4","key":"348_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/gut.2008.148908","volume":"58","author":"B Funke","year":"2009","unstructured":"Funke B, Autschbach F, Kim S, Lasitschka F, Strauch U, Rogler G, Gdynia G, Li L, Gretz N, Macher-Goeppinger S, Sido B, Schirmacher P, Meuer SC, Roth W (2009) Functional characterisation of decoy receptor 3 in Crohn's disease. Gut 58(4):483\u2013491. https:\/\/doi.org\/10.1136\/gut.2008.148908","journal-title":"Gut"},{"issue":"5","key":"348_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s11739-015-1195-7","volume":"10","author":"Y Dong","year":"2015","unstructured":"Dong Y, Shi D, Li M, Dai P, Wang X, Xie M (2015) Elevated serum levels of decoy receptor 3 are associated with disease severity in patients with hemorrhagic fever with renal syndrome. Intern Emerg Med 10(5):567\u2013573. https:\/\/doi.org\/10.1007\/s11739-015-1195-7","journal-title":"Intern Emerg Med"},{"issue":"3","key":"348_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1365-2249.2007.03579.x","volume":"151","author":"CS Lee","year":"2008","unstructured":"Lee CS, Hu CY, Tsai HF, Wu CS, Hsieh SL, Liu LC, Hsu PN (2008) Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus. Clin Exp Immunol 151(3):383\u2013390. https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03579.x","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"348_CR18","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.amjcard.2015.06.041","volume":"116","author":"T-Y Chang","year":"2015","unstructured":"Chang T-Y, Hsu C-Y, Huang P-H, Chiang C-H, Leu H-B, Huang C-C, Chen J-W, Lin S-J (2015) Usefulness of circulating decoy receptor 3 in predicting coronary artery disease severity and future major adverse cardiovascular events in patients with multivessel coronary artery disease. Am J Cardiol 116(7):1028\u20131033. https:\/\/doi.org\/10.1016\/j.amjcard.2015.06.041","journal-title":"Am J Cardiol"},{"issue":"1","key":"348_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12929-017-0347-7","volume":"24","author":"SL Hsieh","year":"2017","unstructured":"Hsieh SL, Lin WW (2017) Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions. J Biomed Sci 24(1):39. https:\/\/doi.org\/10.1186\/s12929-017-0347-7","journal-title":"J Biomed Sci"},{"key":"348_CR20","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.2147\/copd.s175085","volume":"13","author":"A Zhou","year":"2018","unstructured":"Zhou A, Zhou Z, Peng Y, Zhao Y, Duan J, Chen P (2018) The role of CAT in evaluating the response to treatment of patients with AECOPD. Int J Chronic Obstr Pulm Dis 13:2849\u20132858. https:\/\/doi.org\/10.2147\/copd.s175085","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"348_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.rmed.2017.10.011","volume":"132","author":"M Amani","year":"2017","unstructured":"Amani M, Ghadimi N, Aslani MR, Ghobadi H (2017) Correlation of serum vascular adhesion protein-1 with airflow limitation and quality of life in stable chronic obstructive pulmonary disease. Respir Med 132:149\u2013153. https:\/\/doi.org\/10.1016\/j.rmed.2017.10.011","journal-title":"Respir Med"},{"issue":"9435","key":"348_CR22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0140-6736(04)16900-6","volume":"364","author":"JC Hogg","year":"2004","unstructured":"Hogg JC (2004) Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364(9435):709\u2013721. https:\/\/doi.org\/10.1016\/s0140-6736(04)16900-6","journal-title":"Lancet"},{"issue":"26","key":"348_CR23","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1056\/NEJMoa032158","volume":"350","author":"JC Hogg","year":"2004","unstructured":"Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350(26):2645\u20132653. https:\/\/doi.org\/10.1056\/NEJMoa032158","journal-title":"N Engl J Med"},{"issue":"1","key":"348_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","volume":"138","author":"PJ Barnes","year":"2016","unstructured":"Barnes PJ (2016) Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 138(1):16\u201327. https:\/\/doi.org\/10.1016\/j.jaci.2016.05.011","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"348_CR25","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3892\/mmr.2013.1377","volume":"7","author":"R Liang","year":"2013","unstructured":"Liang R, Zhang W, Song YM (2013) Levels of leptin and IL-6 in lungs and blood are associated with the severity of chronic obstructive pulmonary disease in patients and rat models. Mol Med Rep 7(5):1470\u20131476. https:\/\/doi.org\/10.3892\/mmr.2013.1377","journal-title":"Mol Med Rep"},{"issue":"4","key":"348_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1177\/039463200702000411","volume":"20","author":"MP Foschino Barbaro","year":"2007","unstructured":"Foschino Barbaro MP, Carpagnano GE, Spanevello A, Cagnazzo MG, Barnes PJ (2007) Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease. Int J Immunopathol Pharmacol 20(4):753\u2013763. https:\/\/doi.org\/10.1177\/039463200702000411","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"348_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1128\/IAI.72.1.89-93.2004","volume":"72","author":"S Kim","year":"2004","unstructured":"Kim S, McAuliffe WJ, Zaritskaya LS, Moore PA, Zhang L, Nardelli B (2004) Selective induction of tumor necrosis receptor factor 6\/decoy receptor 3 release by bacterial antigens in human monocytes and myeloid dendritic cells. Infect Immun 72(1):89\u201393. https:\/\/doi.org\/10.1128\/IAI.72.1.89-93.2004","journal-title":"Infect Immun"},{"issue":"1","key":"348_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1582-4934.2001.tb00135.x","volume":"5","author":"A Ortiz","year":"2001","unstructured":"Ortiz A, Lorz C, Justo P, Catalan MP, Egido J (2001) Contribution of apoptotic cell death to renal injury. J Cell Mol Med 5(1):18\u201332. https:\/\/doi.org\/10.1111\/j.1582-4934.2001.tb00135.x","journal-title":"J Cell Mol Med"},{"issue":"2","key":"348_CR29","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1183\/09031936.00024608","volume":"33","author":"H Watz","year":"2009","unstructured":"Watz H, Waschki B, Meyer T, Magnussen H (2009) Physical activity in patients with COPD. Eur Respir J 33(2):262\u2013272","journal-title":"Eur Respir J"},{"issue":"4","key":"348_CR30","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1378\/chest.09-0393","volume":"136","author":"H Watz","year":"2009","unstructured":"Watz H, Waschki B, Kirsten A, Muller KC, Kretschmar G, Meyer T, Holz O, Magnussen H (2009) The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest 136(4):1039\u20131046. https:\/\/doi.org\/10.1378\/chest.09-0393","journal-title":"Chest"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-020-00348-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-020-00348-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-020-00348-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:28:53Z","timestamp":1616545733000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-020-00348-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["348"],"URL":"https:\/\/doi.org\/10.1007\/s00408-020-00348-z","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,24]]},"assertion":[{"value":"22 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}